Parkinson's disease
Conditions
Interventions
Parkinsonian subgroup:Individual walking and dual task walking, intelligent vibration-coupled stimulation, 6-minute walking test, fNIRS detection of walking state and dual task state
b. Brain injury hemiplegia subgroup:Individual walking and dual task walking, intelligent vibration-coupled stimulation, 6-minute walking test, fNIRS detection of walking state and dual task state
c. Brain injury consciousness disorder subgroup:Ambulatory EEG, functional magnetic resonance
Health Group - Subgroup A:Individual walking and dual task walking, intelligent vibration-coupled stimulation, 6-minute walking test, fNIRS detection of walking state and dual task state
Health Group - Subgroup B:Ambulatory EEG, functional magnetic resonance
Sponsors
No
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. Inclusion criteria for patients with neurological diseases: (1) Patients with neurological diseases confirmed by imaging or clinical evidence, including patients with brain trauma, cerebral infarction, cerebral hemorrhage, primary Parkinson's disease, Parkinson's syndrome, Parkinson's syndrome, and multiple system atrophy. (2) Stable vital signs. (3) The guardian or patient can understand the purpose of the study, demonstrate sufficient compliance with the study protocol, and sign the informed consent. (4) Age =18 years old, education =6 years.
Exclusion criteria
Exclusion criteria: 1: Exclusion criteria for patients with neurological diseases: (1) unstable vital signs; (2) Patients with skull defect or lower limb defect; (3) Neuropsychiatric diseases other than brain trauma, cerebral infarction, cerebral hemorrhage, primary Parkinson's disease, Parkinson's syndrome, Parkinson's syndrome, and multiple system atrophy; (4) Skin injury, infection, hyperalgesia and irritation area intolerance; (5) Patients with metal foreign bodies in the skull or with cardiac pacemakers, patients with cardiac stent implantation, patients with cochlear implants, and patients with significantly increased intracranial pressure; (6) Female subjects with positive pregnancy tests during pregnancy or lactation or screening period; (7) Previous history of epilepsy; (8) The patient or his family members did not sign the informed consent. 2. Exclusion criteria for healthy subjects: (1) Current or past serious organic or functional disease; (2) Researchers who cannot cooperate to complete the experiment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Gait parameter; | — |
Countries
China
Contacts
Public ContactKong Ying
The Second Xiangya Hospital, Central South University
Outcome results
None listed